US FDA United States — FDA approvals (Drugs@FDA)
| Product | Strength | Form · route | Applicant | Status | First approved |
| PHOTOFRIN | 75MG/VIAL | injectable · injection | PINNACLE BIOLGS | Prescription | 27 Dec 1995 |
| PHOTOFRIN | 75MG/VIAL | injectable · injection | AXCAN SCANDIPHARM | Prescription | 1 Aug 2003 |
EMA European Union — centrally authorised medicines
PhotoBarr Pinnacle Biologics B.V. · Withdrawn · authorised 25 Mar 2004 · ATC L01XD01
Therapeutic indication (EMA)
Photodynamic therapy (PDT) with PhotoBarr is indicated for: Ablation of high-grade dysplasia (HGD) in patients with Barrett's Oesophagus (BO)
Values as published by each source: SFDA human drug list (4-2026, as published by the Council of Health Insurance; indications from the CHI Daman Drug Formulary), Drugs@FDA, EMA medicines data, Health Canada Drug Product Database (Open Government Licence – Canada), CMS NADAC, NHS Drug Tariff Part VIIIA (NHSBSA Copyright, Open Government Licence v3.0), WHO Model List of Essential Medicines (CC BY 3.0 IGO; regrouped by active substance, not created by WHO), EMA PRAC, US FDA safety-related labeling changes and MHRA Drug Safety Update (Open Government Licence v3.0). Sources and reuse. Not a substitute for the official registers or the product information.